Specific, clinically observable dermatological signs and symptoms that are strongly associated with underlying systemic insulin resistance and hyperinsulinemia. These cutaneous manifestations serve as visual diagnostic clues for a metabolic derangement that often precedes the onset of type 2 diabetes and cardiovascular disease. Key markers include acanthosis nigricans, skin tags (acrochordons), and certain patterns of acne or hirsutism.
Origin
This term is a clinical synthesis of “insulin resistance” (the metabolic condition), and “cutaneous markers” (the observable skin signs). Its origin lies in the intersection of endocrinology, metabolism, and dermatology, where clinicians recognized the frequent co-occurrence of these skin findings with hyperinsulinemic states. These markers offer a non-invasive opportunity for early metabolic screening.
Mechanism
Elevated circulating insulin and IGF-1 levels, characteristic of insulin resistance, bind to and activate IGF-1 receptors and hybrid insulin/IGF-1 receptors on keratinocytes and dermal fibroblasts. This excessive signaling stimulates keratinocyte proliferation, leading to the hyperpigmentation and velvety thickening seen in acanthosis nigricans. Furthermore, hyperinsulinemia can increase ovarian and adrenal androgen production, contributing to androgen-dependent cutaneous signs like acne and hirsutism.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.